AVXL has been in the news 357% more than usual
Jan 16, 2025, 9:31 PM
-15.89%
What does AVXL do
Anavex Life Sciences, a New York-based biopharmaceutical company, develops therapeutics for neurodegenerative diseases and employs 40 staff. Its lead compound, ANAVEX 2-73, targets Alzheimer's and Parkinson's diseases.
AVXL has been in the news recently: ANAVEX LIFE SCIENCES is not directly mentioned in the provided information, which primarily focuses on QIAGEN N.V. and TetraScience's partnership with Microsoft. QIAGEN N.V. is set to release its fourth quarter 2024 results on February 5, and it plans to execute a $300 million synthetic share repurchase by January 29, 2025.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.